These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6684573

  • 1. Catabolism of 6 keto PGE1: biological activation by the rat kidney in vitro.
    Moore PK, Griffiths RJ, Gaffen ZA.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):311-5. PubMed ID: 6684573
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U, Stahl T, Hackenthal E.
    Prostaglandins; 1982 Jan 22; 23(1):129-38. PubMed ID: 7038776
    [Abstract] [Full Text] [Related]

  • 3. Formation of 6-keto prostaglandin E1 in mammalian kidneys.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 May 22; 79(1):149-55. PubMed ID: 6347300
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent changes in the synthesis and catabolism of 6 oxo PGE1 and other prostanoids by the rat kidney in vitro.
    Griffiths RJ, Berry CN, Hoult JR, Moore PK.
    Biochem Pharmacol; 1985 Jan 15; 34(2):223-8. PubMed ID: 3881101
    [Abstract] [Full Text] [Related]

  • 5. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
    Berry CN, Hoult JR.
    Pharmacology; 1983 Jan 15; 26(6):324-30. PubMed ID: 6348806
    [Abstract] [Full Text] [Related]

  • 6. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 Oct 15; 80(2):395-402. PubMed ID: 6360281
    [Abstract] [Full Text] [Related]

  • 7. Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lung.
    Berry CN, Griffiths RJ, Hoult JR, Moore PK, Taylor GW.
    Br J Pharmacol; 1986 Feb 15; 87(2):327-35. PubMed ID: 3955304
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of 6-oxo-prostaglandin E1 on human platelet aggregation in whole blood in-vitro.
    Wilsoncroft PS, Lofts FJ, Griffiths RJ, Moore PK.
    J Pharm Pharmacol; 1985 Feb 15; 37(2):139-41. PubMed ID: 2858551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: comparison with prostaglandin E1.
    Berry CN, Hoult JR, Griffiths RJ, Moore PK.
    Biochem Pharmacol; 1984 Apr 15; 33(8):1277-84. PubMed ID: 6549614
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of 6-keto-prostaglandin E1 obtained from isolated perfused kidney of the rabbit.
    Pieroni JP, Dray F, Pace-Asciak CR, McGiff JC.
    J Pharmacol Exp Ther; 1988 Oct 15; 247(1):63-8. PubMed ID: 3139870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC, Spokas EG, Wong PY.
    Br J Pharmacol; 1982 Jan 15; 75(1):137-44. PubMed ID: 7042021
    [Abstract] [Full Text] [Related]

  • 16. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY, McGiff JC, Sun FF, Lee WH.
    Eur J Pharmacol; 1979 Dec 07; 60(2-3):245-8. PubMed ID: 393526
    [Abstract] [Full Text] [Related]

  • 17. 9-Hydroxyprostaglandin dehydrogenase in rat kidney cortex converts prostaglandin I2 into 15-keto-13,14-dihydro 6-ketoprostaglandin E1.
    Pace-Asciak CR, Domazet Z.
    Biochim Biophys Acta; 1984 Nov 14; 796(2):129-35. PubMed ID: 6388642
    [Abstract] [Full Text] [Related]

  • 18. Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism?
    Mikhailidis DP, Mikhailidis AM, Woollard ML, Dandona P.
    Clin Sci (Lond); 1982 Feb 14; 62(2):177-81. PubMed ID: 7032807
    [Abstract] [Full Text] [Related]

  • 19. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1980 Jun 14; 213(3):468-72. PubMed ID: 7193724
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the pulmonary, hepatic and renal extraction of PGI2 and 6-keto-PGE1.
    Tsunoda S, Jackson EK, Branch RA, Gerkens JF.
    Eur J Pharmacol; 1982 Jan 22; 77(2-3):147-51. PubMed ID: 7037431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.